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Abstract
Glutathione transferases (GSTs) are enzymes that contribute to cellular detoxification by catalysing the nucleophilic attack of
glutathione (GSH) on the electrophilic centre of a number of xenobiotic compounds, including several chemotherapeutic
drugs. In the present work we investigated the interaction of the chemotherapeutic drug chlorambucil (CBL) with human
GSTA1-1 (hGSTA1-1) using kinetic analysis, protein crystallography and molecular dynamics. In the presence of GSH, CBL
behaves as an efficient substrate for hGSTA1-1. The rate-limiting step of the catalytic reaction between CBL and GSH is
viscosity-dependent and kinetic data suggest that product release is rate-limiting. The crystal structure of the hGSTA1-1/
CBL-GSH complex was solved at 2.1 A˚ resolution by molecular replacement. CBL is bound at the H-site attached to the thiol
group of GSH, is partially ordered and exposed to the solvent, making specific interactions with the enzyme. Molecular
dynamics simulations based on the crystal structure indicated high mobility of the CBL moiety and stabilization of the C-
terminal helix due to the presence of the adduct. In the absence of GSH, CBL is shown to be an alkylating irreversible
inhibitor for hGSTA1-1. Inactivation of the enzyme by CBL followed a biphasic pseudo-first-order saturation kinetics with
approximately 1 mol of CBL per mol of dimeric enzyme being incorporated. Structural analysis suggested that the
modifying residue is Cys112 which is located at the entrance of the H-site. The results are indicative of a structural
communication between the subunits on the basis of mutually exclusive modification of Cys112, indicating that the two
enzyme active sites are presumably coordinated.
Citation: Karpusas M, Axarli I, Chiniadis L, Papakyriakou A, Bethanis K, et al. (2013) The Interaction of the Chemotherapeutic Drug Chlorambucil with Human
Glutathione Transferase A1-1: Kinetic and Structural Analysis. PLoS ONE 8(2): e56337. doi:10.1371/journal.pone.0056337
Editor: Sotirios Koutsopoulos, Massachusetts Institute of Technology, United States of America
Received October 22, 2012; Accepted January 8, 2013; Published February 27, 2013
Copyright:  2013 Karpusas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research has been co-financed by the European Union (European Social Fund – ESF) and Greek national funds through the Operational Program
‘‘Education and Lifelong Learning’’ of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. The work was also supported
by the action THALES: ‘Glutathione transferases: multifunctional molecular tools in red and green biotechnology’, falling under the Operational Programme
‘‘Education and Lifelong Learning’’ and is co-financed by the European Social Fund and National Resources. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: lambrou@aua.gr
Introduction
Glutathione transferases (GSTs) are a family of Phase II
detoxification enzymes that catalyse the conjugation of the
tripeptide glutathione (c-Glu-Cys-Gly, GSH) to a wide variety of
electrophilic compounds. Human cytosolic GSTs, on the basis of
their amino acid sequence, can be divided into the following eight
classes: alpha, mu, pi, sigma, theta, zeta, kappa and omega [1–5].
Structural studies have shown that GSTs are dimeric enzymes
with each subunit containing a GSH-binding site (G-site) and a
second adjacent hydrophobic binding site for the electrophilic
substrate (H-site) [2]. Amino acid variations of the H-site, among
the different GST classes, determine substrate specificity.
GSTs are considered as a drug targets since specific isozymes
are overexpressed in a variety of tumour cells [6–9]. The
development of chemotherapy resistant tumour cells is a
significant problem encountered in cancer chemotherapy. GSTs
have been implicated in the development of resistance toward
chemotherapy agents [7–9]. A possible origin for this problem
appears to be an increase in the expression of total GST activity. It
is possible that GSTs confer drug resistance by two distinct means:
by direct inactivation (detoxification) of chemotherapeutic drugs
and by acting as inhibitors of the mitogen-activated protein (MAP)
kinase pathway [8]. Furthermore, GSTs have been identified as
inhibitors of stress-activated kinase activities, thereby protecting
cells against apoptosis in response to cellular stress from reactive
oxygen species. In addition, it has been shown that GSTA1
suppresses activation of JNK (c-Jun N-terminal kinase) signalling
by a pro-inflammatory cytokine and oxidative stress, thus
indicating a possible protective role for GSTA1-1 against JNK-
associated apoptosis [10].
The catalytic function of the GSTs is far from completely
characterized [6–9]. Various electrophilic xenobiotics are used as
substrates by GSTs. Electrophilic centres for GSH conjugation are
found in areneoxides, aliphatic and arylic halides, in carbonyls,
organonitro-esters, organic thiocyanates, including certain chemo-
therapeutic drugs [3,5,6]. Identification of the GST-mediated
pathway for drug cleavage has been useful for elucidating the
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mechanism of metabolic biotransformation of compounds that
have been brought forward for clinical studies and, furthermore,
enables the design of new molecules that exhibit improved efficacy
and pharmacokinetic characteristics [11,12]. Chlorambucil (CBL)
is a nitrogen mustard alkylating drug that is mainly used in the
treatment of chronic lymphocytic leukemia [13]. Human GSTA1-
1 (hGSTA1-1) is an effective catalyst for chlorambucil conjugation
with GSH [14–16]. It has been reported that combined expression
of GSTA1-1 and multidrug resistant protein 1 (MRP1) or
multidrug resistant protein 2 (MRP2) in MCF-7 cells confers
resistance to CBL [14,17]. Expression of GSTA1-1 alone in MRP-
deficient MCF-7 cells failed to confer resistance to CBL, since the
CBL-GSH conjugate rapidly accumulates to levels that completely
inhibit GSTA1-1 catalysis of CBL conjugation.
The present work combines kinetic, crystallographic and
computational dynamics approaches for studing the interaction
of the chemotherapeutic drug CBL with hGSTA1-1. The results
of the present study provide an insight at the molecular level on
the mechanism of cancer cell resistance against CBL therapy.
Materials and Methods
Materials
GSH, 1-chloro-2,4-dinitrobenzene (CDNB), CBL and all other
reagents and analytical grade chemicals were obtained from
Sigma-Aldrich Co (USA).
Methods
Cloning, expression and purification of hGSTA1-
1. Cloning, expression and purification of hGSTA1-1 was
carried out as described by Axarli et al. (2009) [9]. Before kinetics
analysis the purified enzyme was incubated with 10 mM
dithiothreitol to ensure complete reduction of cysteine residues,
followed by extensive ultrafiltration against potassium phosphate
buffer (20 mM, pH 7.0). Before crystallization the enzyme was
subjected to dialysis against Tris/HCl buffer (10 mM, pH 7.0).
Assay of enzyme activity and protein. GST assays were
performed by monitoring the formation of the conjugate between
CDNB and GSH at 340 nm (e= 9.6 mM21?cm21) according to a
published method [18]. Alternatively, GST assays using CBL and
GSH were performed 37uC by measuring the rate of chloride ion
released using the methods of Skopelitou and Labrou (2010) [19].
Observed reaction velocities were corrected for spontaneous
reaction rates when necessary. Enzyme-dependent catalysis was
determined by subtracting observed rates for conjugate formation
in the absence of GSTA1-1 from observed rates in the presence of
GSTA1-1. Kinetic constants were calculated from the initial
velocities of enzyme-dependent conjugate formation fitted to the
Michaelis-Menten equation using the computer program GraFit
[20]. All initial velocities were determined in triplicate in buffers
equilibrated at constant temperature. One unit of enzyme is
defined as the amount of enzyme that produces 1.0 mmole of
product per minute.
Viscosity dependence of kinetic parameters. The effect
of viscosity on kcat was studied at 37uC, in 0.1 M potassium
phosphate buffer, pH 6.5, containing variable glycerol concentra-
tions. Viscosity values (g) were calculated as described in [21,22].
Glycerol does not induce changes in the enzyme secondary
structure as detected by far-UV difference spectroscopy. Further-
more, glycerol does not have any inhibitory effect on catalysis.
X-ray crystallography. For the crystallization, protein
(19.7 mg/mL) was incubated with CBL at a 1:3 molar ratio and
the solution was mixed with equal volume of reservoir solution
containing 17–20% PEG 2000, 0.1 M Tris-HCl pH 7.5, 0.1 mM
b-mercaptoethanol. Hanging or sitting drops of the mixture were
placed over the reservoir solution and crystals were grown by
vapor diffusion at 20uC. The crystals appeared after 2–3 days, but
were used for data collection after 2–3 months. For cryoprotection,
crystals were rapidly transferred to a solution of 30% PEG 2000,
0.1 M Tris-HCl pH 7.5 and were flash-frozen in liquid nitrogen.
X-ray diffraction data were collected at 110u K, using an RAXIS-
IV detector mounted on a Rigaku rotating anode generator
producing CuKa radiation (Rigaku-MSC, Woodlands TX). The
data were processed with the HKL program package [23]. The
crystal structure was solved by molecular replacement and
difference Fourier map techniques. Crystallographic refinement
was done with the CNS program package [24] and molecular
graphics manipulations were done with the program Coot [25].
Additional crystallographic statistics are shown in Table 1. Atomic
coordinates have being deposited in the RCSB Protein Data Bank
with accession code 4HJ2.
Molecular Dynamics. The crystal structure of hGSTA1-1/
GSH-CBL complex was used for the preparation of all simulation
systems. GST residues Lys4–Phe220 were only considered for
both monomers, whereas solvent molecules were removed. The
missing residues Cys112–Glu115 (monomer B) were modeled by
using the corresponding coordinates of monomer A, when
superimposed with monomer B. Hydrogen and other heavy
atoms were added using the XLEaP module of AMBER 9 [26].
Histidine protonation states were manually set by examining the
surrounding microenvironment of each imidazole ring. Specifi-
cally, His8 and His143 were protonated at Ne2 due to their
hydrogen bonding interaction with Oe2 of Glu59 and C = O of
Leu148, respectively, while His159 was set to be protonated at Nd1
because of the observed Ne2…H–Ne (Arg155) interaction. All other
basic residues were protonated and all acidic residues were
deprotonated. The modified PARM99SB force field parameters
were applied to the protein atoms using XLEaP [27]. Ligand force
field parameters were retrieved from the GAFF set and AM1-BCC
Table 1. Crystallographic data collection and refinement
statistics.
Space group C2
a (A˚) 99.00
b (A˚) 93.53
c (A˚) 51.42
b (u) 93.91
Resolution range (A˚) 20.0–2.1
Unique reflections 23814
Completeness (%)a 87.2 (84.9)
I/s(I) 13.16 (2.76)
Rmerge
b 5.0 (22.9)
Rfact (%) 21.5
Rfree (%)
c 25.8
Water molecules 299
Average B-value (A˚2) 28.1
RMSD (bonds) (A˚) 0.007
RMSD (angles) (A˚) 1.346
(a)The values in parenthesis refer to the highest resolution shell (2.18–2.1 A˚).
(b)Rmerge =ShSi |Ihi-Ih|/ShiIhi.
(c)Rfree was calculated against 5% of the reflections removed at random.
doi:10.1371/journal.pone.0056337.t001
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atomic charges were calculated using the ANTECHAMBER
module of AMBER [28].
Three simulation systems were employed for molecular
dynamics: a) the apo hGSTA1-1 dimer lacking all ligand
coordinates, b) the holo hGSTA1-1/GSH–CBL dimer and c)
the hGSTA1-1/GSH model prepared by removing the coordi-
nates of CBL atoms. In order to relax them from crystal-packing
contacts and optimize the position of hydrogen atoms, a set of
minimization rounds were carried out with the SANDER module
of AMBER. First, 1000 minimization steps were performed in
order to allow relaxation of hydrogen atoms only, then 1000 steps
for the ligands and the residues with missing atoms, and finally,
3000 steps of conjugate gradient minimization restraining only the
protein Ca atoms. Positional harmonic restraints were imposed
accordingly using a force constant of 50 Kcal?mol21?A˚22. The
generalized Born solvation model GBHCT was employed using a
16-A˚ cutoff for truncation of nonbonded interactions. Subse-
quently, the simulation dimmers were immersed in isometric
truncated octahedra of pre-equilibrated TIP3P waters using a
buffer of 8 A˚ and the appropriate number of chloride ions was
added to neutralize the total charge. The PMEMD module of
AMBER 9 was used for the molecular dynamics calculations.
Numerical integration was performed with a 2-fs time step, and all
bonds involving hydrogen atoms were constrained with SHAKE.
Periodic boundary conditions were imposed by means of the
particle-mesh Ewald method with an 8-A˚ limit for the direct space
sum. Temperature and pressure controls were imposed using a
Berendsen-type algorithm with coupling constants of 1 ps for the
thermostat and 2 ps for the barostat. Prior to the production run,
all systems were equilibrated as described below.
Initially, water molecules and ions were subjected to energy
minimization for 1000 steps, of which 100 steps employed the
steepest descent algorithm and 900 employed conjugate gradients.
Protein atoms were restrained harmonically with a 50 Kcal?-
mol21?A˚22 force constant. While all solute atoms were still
restrained, the temperature was increased to 300 K through 20 ps
of constant volume dynamics (NVT ensemble). A second round of
1000-step energy minimization using conjugate gradients was then
carried out by restraining only the protein Ca atoms. Subse-
quently, all restraints were removed and the system temperature
was increased to 300 K within six 10-ps rounds in the NVT
ensemble. The systems were then equilibrated at 1 atm through-
out 150 ps of constant pressure dynamics (NPT ensemble).
Production runs were carried out in the NPT ensemble for a
total of 10 ns each. The translational center-of-mass motion was
removed every 2 ps, while trajectories were updated every single
ps. Post-simulation analysis was performed using the PTRAJ
module of AMBER and the trajectories were inspected in VMD
1.8.6 [28,29].
Enzyme inactivation studies by CBL. Inactivation of
hGSTA1-1 was performed in 1 mL of incubation mixture
containing potassium phosphate buffer pH 7 (100 mmol), CBL
(0.5–3.0 mM) and enzyme, (0.1 units). The rate of inactivation was
followed by periodically removing samples (5–20 mL) for assay of
enzymatic activity [30,31]. Rate constants for the reaction
exhibiting biphasic kinetics were calculated using the equation
[32,33]:
Remaining activity~ 1{Fð Þe{kfasttzFe{kslowt
where F represents the fractional residual activity of the partial
active enzyme intermediate. kfast and kslow are the rate constants
for the slow and fast phase of the reaction. Analysis was achieved
using the GraFit [20] computer program. KD determinations were
performed according to King et al. (1983) [32] and Wang et al.,
(1998) [33].
Inactivation studies of hGSTA1-1 by CBL in the presence of S-
nitrobenzyl-GSH were performed in 1 mL of incubation mixture
containing potassium phosphate buffer pH 7 (100 mmol), CBL,
(2 mM), S-nitrobenzyl-GSH (1 mM) and enzyme (0.1 units).
MALDI-TOF MS. Enzyme samples (hGSTA1-1 and
hGSTA1-1-CBL conjugate) were desalted with ZipTip m-C18
(Millipore, USA). A saturated solution of sinapinic acid in water/
acetonitrile (50/50, v/v, 0.1% trifluoroacetic acid) was used as the
matrix solution. One mL of the sample and matrix mixture was
spotted into a well of the sample plate and dried on the sample
holder. Mass spectra were taken with a Voyager System 6322
(Applied Biosystems). Mass calibration was performed using
bovine serum albumin, apomyoglobin and cytochrome c.
Modification of hGSTA1-1 with DTNB and
maleimide. Determination of enzyme cysteine-SH groups with
5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB) was based on the
Ellman’s method [35]. The assay was carried out in 100 mM
potassium phosphate buffer, pH 7.6, in the presence of 1 mM
DTNB. The resultant nitrophenyl anions from the reaction were
quantified from the change of absorbance at 412 nm. Control
incubation in the absence of hGSTA1-1 was taken to correct the
above determinations for alkaline hydrolysis of DTNB. Modifica-
tion of hGSTA1-1 by maleimide (1 mM) was carried out
according to Lyon and Atkins (2002) [36].
Determination of the stability of CBL. The rate of
decomposition of CBL in a buffer identical to that used in the
inactivation studies (100 mM potassium phosphate buffer pH 7)
was determined by following the time dependent release of
chloride ions using the method of Skopelitou and Labrou, 2010
[19].
Results
The interaction of CBL with hGSTA1-1 in the presence of
GSH
Kinetic analysis and the rate-limiting step of the CBL/
GSH catalytic reaction. hGSTA1-1 is an effective catalysts for
CBL conjugation with GSH (Figure 1A) [14,37,38] leading to the
formation of the monoglutathionyl derivative of CBL but not the
diglutathionyl, one [15,16]. Whether GSH was used as a variable
substrate with several fixed concentrations of CBL, an intersecting
pattern of Lineweaver-Burk plot was obtained (Figure 1B), and
with CBL as the variable substrate at fixed concentrations of GSH,
an intersecting pattern was again obtained (Figure 1C), suggesting
a sequential kinetic mechanism for this enzyme.
The viscosity effect on kcat was investigated to determine the
nature (physical or chemical event) of the rate-limiting step of the
catalytic reaction (Figure 1D) [18,39,40]. The decrease of kcat by
increasing the medium viscosity shows that the rate-limiting step of
the catalytic reaction is related to the product release or to
diffusion-controlled structural transitions of the protein [41,42]. In
particular, a plot of the inverse relative rate constant kcat
o/kcat,
(kcat
o is determined at viscosity go) versus the relative viscosity g/
go should be linear with a slope equal to unity if a physical step is
the rate-determining one, whereas a slope of zero indicates that a
chemical reaction step is the rate limiting one [40–42]. The
enzyme displayed a linear dependence with a slope of approx. 1.0
(slope = 1.0160.06) (Figure 1D), suggesting that a physical step of
the reaction that effects product release and/or structural
transition is the rate-limiting determinant.
Crystallographic analysis. The hGSTA1-1 enzyme was
crystallized in the presence of CBL and the X-ray crystal structure
The Interaction of Chlorambucil with hGSTA1-1
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was determined by molecular replacement at 2.1 A˚ resolution.
The crystal form of hGSTA1-1 obtained is identical to a
previously reported crystal form [43,44]. Table 1 summarizes
relevant crystallographic statistics. The final model includes
hGSTA1-1 residue ranges 4–220 for monomer A (Figure 2A)
and 3–221 for monomer B that fit satisfactorily into the electron
density map. In addition, residues 112–115 of monomer B are not
included in the model due to non-interpretable electron density.
Figure 1. Kinetic analysis of the CBL/GSH reaction catalyzed by hGSTA1-1. (A): Reaction between CBL and GSH catalyzed by hGSTA1-1. (B):
Initial velocity analysis with GSH as the variable substrate (0.15–1.05 mM) for several fixed concentrations of CBL (mM): 0.1, (%); 0.2, (N); 0.4, (#). (C):
Initial velocity analysis with CBL as a variable substrate (0.02–0.5 mM) for several fixed concentrations of GSH (mM): 0.5, (%); 1.0, (N); 2.0, (#). (D): The
effect of viscosity on turnover number. Plot of the reciprocal of the relative turnover number (kocat/kcat) as a function of relative viscosity (g/g
o) with
glycerol as a cosolvent. Experiments were performed in triplicate and lines were drawn by least-squares regression analysis.
doi:10.1371/journal.pone.0056337.g001
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All residues are within the allowed regions of the Ramachadran
diagram, with the exception of Gln47 which has well defined
electron density and has been observed to adopt the same unusual
conformation in other GSTA1-1 crystal structures [43–45].
Difference Fourier electron density maps indicate the presence
of a GSH moiety in the G-site of the enzyme (Figure 2B). Even
although GSH was not included in the crystallization solution, it
was apparently still present in the protein sample used. It most
likely originated from previous use in the elution step from the
affinity chromatography step on GSH-Sepharose adsorbent. The
GSH moiety is well ordered and adopts a conformation essentially
identical to that observed in the previously reported GSTA1-1
structures [43–45]. Specifically it forms a salt bridge with Arg131
and hydrogen bonds with the side chains of Thr68 and Asp101
and the main chain carbonyl of Val55 (Figure 2C). Additional
interactions include van der Waals and hydrophobic contacts as
well as polar interactions mediated by water molecules.
Electron density is observed indicating the presence of a
chemical moiety in the H-site that is attached to the thiol group of
GSH that is bound to both monomers. The electron density
feature is more prominent for the binding site of monomer A and
has a shape consistent with a portion of the CBL moiety,
conjugated with bound GSH (Figure 2B and Figure S1). For both
monomers, there is no electron density for the carboxylate moiety
of CBL and for monomer B, the remaining CBL density becomes
progressively poorer going from the thiol group to the aromatic
ring of CBL. These may be consequences of the high mobility of
the CBL moiety due to its extensive exposure to the solvent and
lack of specific interactions. The results of the molecular dynamics
study discussed as part of this work, are consistent with this
possibility. Furthermore, the average value of the final B-factors
Figure 2. Crystal structure of hGSTA1-1/GSH–CBL complex. (A) Ribbon representation of monomer A with the GSH–CBL adduct atoms shown
as van der Waals spheres and coloured orange for C, blue for N, red for O, yellow for S and green for Cl. (B) Representative 2Fo-Fc electron density
map contoured at 1s in the vicinity of bound GSH–CBL superimposed on refined crystal structure (left) in comparison with the simulated GSH–CBL
adduct coloured according to the B-factor calculated from 10-ns molecular dynamics (right). (C) Residue-specific interactions of CBL moiety (orange
licorice) in monomer A (cyan licorice). (D) Residue-specific interactions of the GSH moiety (orange licorice) from monomer A (blue ribbons) and
monomer B (red ribbons).
doi:10.1371/journal.pone.0056337.g002
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for CBL is 60.58 and for GSH is 27.42. Similar observations and
conclusions were reported for hGSTA1-1 in the cases of
ethacrynic acid-GSH and of S-hexyl-GSH complexes [43,44].
Another possibility may be partial occupancy of the H-site by
CBL.
Comparison of the structure with those of previously reported
hGSTA1-1/GSH complexes shows very few differences in the
position of the GSH atoms with the exception of the thiol group of
GSH which rotates in order to accommodate the bond with the
CBL moiety. However, the thiol group maintains an interaction
with the catalytically important residue Tyr9. Several van der
Waals and hydrophobic contacts exist between the CBL moiety
and several residues including Gly14, Leu107, Leu108, Val111,
Met208 and Phe220 (Figure 2C). The chloroethyl group of CBL
appears to be relatively flexible and does not form any contact with
protein residues. The CBL moiety is located in a position very
similar to that of ethacrynic acid moiety in the hGSTA1-1/GSH-
ethacrynic acid conjugate, albeit shifted by about 1 A˚ with respect
to each other (PDB entry 1GSE), [43]. Comparison of the two
structures shows few differences in the position of the protein side
chains, with the exception of Phe10 side chain which rotates in
order to form van der Waals contacts with the aromatic ring of
CBL and significant differences in the positions of C-helix residues,
in particular that of Met208 (Figure 2C). Interactions between
CBL and the helix residues may be responsible for the apparent
stabilization of the C-terminal helix H9 for monomer A, which in
the structure of GSTA1-1 in complex with S-hexyl-GSH (PDB
entry 1YDK) is not part of the model and is presumably
disordered [44]. In the 1YDK structure, the same helix for
monomer B was ordered due to packing interactions.
Molecular dynamics simulations
To investigate the effects of ligand binding on the conformation
and the dynamics of the enzyme, molecular dynamics simulations
(MDs) of the apo hGSTA1-1 dimer were compared with those of
the holo complex with the GSH–CBL adduct and the complex
with GSH alone. The root mean square positional fluctuations of
each Ca atom during the course of the MDs (Figure 3) indicate
that binding of the GSH–CBL adduct results to an overall
stabilization of the hGSTA1-1 dimer, as exhibited by the lower
atomic fluctuations of the holo hGSTA1-1 complex with respect to
the apo enzyme. This effect is more pronounced for helices H2
(residues 37 to 48) and H9 (residues 210 to 220), whereas the
major part of H4 and H5 (residues 85 to 144) are slightly less
mobile in the holo dimer (Figure 3). Interestingly, the same
stabilization effect is evident in the MDs of hGSTA1-1/GSH
complex, which exhibit a very similar mobility profile with respect
to the hGSTA1-1/GSH–CBL complex (Figure S2). This obser-
vation indicates that binding of CBL at the hGSTA1-1/GSH
complex is only marginally affecting the dynamics of the dimer.
As mentioned above, analysis of the MDs indicates that the
CBL moiety is considerably more mobile than the GSH moiety,
which is consistent with the progressively weaker electron density
characterizing the CBL moiety (Figure 2B). In accordance, the
root mean square deviation of the GSH atoms as a function of
simulation time is evidently lower than that of CBL moiety (Figure
S3). To illustrate the difference in the dynamics of the GSH–CBL
adduct, three snapshots from the MDs of the holo hGSTA1-1
dimer are shown in Figure 4. The higher rigidity of the GSH
moiety is evident throughout the 10 ns simulations in contrast to
the CBL adduct, which exhibit major conformational changes.
The chloroethyl moiety of CBL exhibits the higher mobility and is
predicted to adopt several conformations that may even disrupt
the p–p interactions of Phe10 and Phe220 (Figure 4C). The
butyloxy moiety is predicted to be partially stabilized by a
hydrogen bonding interaction with the backbone amide of Met208
(Figure 4B) and therefore exhibiting relatively lower fluctuations.
On the other hand, the interacting residues from H9 are slightly
perturbed by the high mobility of the CBL adduct and, in concert
with H2, exhibit lower flexibility than in the apo enzyme.
The interaction of CBL with hGSTA1-1 in the absence of
GSH
Chemical modification of hGSTA1-1 with CBL. When
hGSTA1-1 was incubated with CBL in the absence of GSH at
pH 7, the enzyme was progressively inactivated (Figure 5),
whereas in the absence of CBL, virtually no change in activity
was observed when the enzyme was incubated under identical
conditions. The inactivation of hGSTA1-1 by CBL was irrevers-
ible, and activity was not recovered either by extensive dialysis or
gel filtration on Sephadex G-25. The kinetics of inactivation was
biphasic (Figure 5), with the rapid reaction occurring immediately
upon exposure of the enzyme to CBL followed by and the slow
inactivation process to a final residual activity of approximately
22%. At all CBL concentrations used, biphasic kinetics were
observed. The ability of specific ligands (e.g. substrates and
inhibitors) to prevent enzyme inactivation by an irreversible
inhibitor is usually taken as evidence that the inhibitor is either
active site directed or affected by conformational changes resulting
from ligand binding at the active site [30,33,46]. The effect of
GSH analogue S-nitrobenzyl-GSH on the reaction of CBL with
hGSTA1-1 was investigated (Figure 5). S-nitrobenzyl-GSH pro-
tects hGSTA1-1 from inactivation by CBL, indicating the
specificity of the enzyme-CBL reaction.
The observed rate of inactivation for the fast and slow phases
was dependent upon CBL concentration, as illustrated in Figure 6.
This indicated that the reaction obeyed pseudo-first-order
saturation kinetics and was consistent with reversible binding of
reagent prior to covalent modification according to the following
equation:
EzCBL ?
KD
E : CBL?
k3
E-CBL
where E represents the free enzyme, E:CBL is the reversible
complex and E-CBL is the covalent product. The steady-state rate
equation for the interaction is [30,33,34,46,47]:
kobs~
k3 CBL½ 
KDz CBL½ 
Figure 3. Root mean square fluctuations (RMSF) of hGSTA1-1
Ca atoms calculated for the apo (black) and the holo complex
with GSH–CBL (red) from 10-ns molecular dynamics simula-
tions. The graph shows the mean RMSF value of the two monomers.
doi:10.1371/journal.pone.0056337.g003
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where kobs is the observed rate of enzyme inactivation for a given
concentration of CBL, k3 is the maximal rate of inactivation
(min21), and KD is the apparent dissociation constant of the
E:CBL complex. From the data shown in Figure 6, KD values of
2.9560.5 mM and 6.0560.8 mM, for the fast and slow reactions,
respectively, were determined. Apparent maximal rate constants
(k3) were determined equal 0.7260.15 min
21 for the fast reaction
and 0.0460.01 min21 for the slow reaction.
The stability of CBL against non enzymatic hydrolysis was
demonstrated by measuring the rate of chloride ions release in
conditions identical to those used in the enzyme inactivation
experiments. The results showed that the first-order rate constant
for CBL hydrolysis was 0.861025 min21. This corresponds to
0.0003% and 0.02% of the rate observed for the slow and fast
phase, respectively. This suggests that the slow phase of
inactivation observed is not due to the decomposition of CBL
and is the direct result of CBL-enzyme interaction [46].
Stoichiometry and identification of hGSTA1-1 residue
modified by CBL. To determine the stoichiometry of incorpo-
ration of CBL, modified and unmodified enzyme were subjected
to MALDI-TOF MS analysis. The result of this experiment
showed that the mass spectrum of unmodified enzyme gives a
major peak centered at m/z = 25,482. The mass spectrum of CBL-
modified enzyme shows an additional major peak whose mass is
about 269 mass units higher (which is close to the mass of CBL)
than that of the first major peak, which corresponds to the
unmodified enzyme subunit. This indicates that only one of the
two subunits is modified by CBL, while the other remains intact.
In order to identify the amino acid residue modified, amino acid
analysis and molecular modelling were employed. Direct amino
acid sequence determination of the CBL-modified peptide was not
possible due to its instability during Edman degradation reactions.
Earlier findings [36] point out that Cys112 of hGSTA1-1 appears
to be the most reactive residue against cysteine-reactive reagents,
such as CBL. To analyse whether Cys112 is the nucleophile target
for CBL, total cysteine determination using DTNB was carried out
for the modified and free enzyme. The results from a total cysteine
determination indicated that the modified enzyme shows loss of
0.8760.21 mol of Cys/mol enzyme dimer, which is close to unity.
The enzyme has one Cys residue per subunit (Cys112). From the
analysis of the enzyme crystal structure it is evident that Cys112
lies adjacent to the hydrophobic substrate binding site and is
located on the loop connecting helices H4 and H5 (Figure 7). Its
side chain thiol is accessible for covalent modification by CBL and
projects into the large, solvent-filled cleft which is widely reported
in the literature to be the binding site of nonsubstrate ligands [45].
To provide further experimental evidence and establish the
involvement or not of Cys121 in the reaction with CBL, chemical
modification with maleimide was carried out on the basis of the
known [36] susceptibility of Cys112 for modification by mal-
eimides. The maleimide-modified enzyme retains most of its
activity (92%), indicating that modification at Cys112 has little
effect on the catalytic turnover of CDNB. The results of the
present study showed that the maleimide-modified enzyme is
resistant to inactivation by CBL, compared to the wild-type
enzyme (Figure 5). Inspection of the electron density map in the
vicinity of Cys112 for monomer B suggests the presence of
multiple conformations for the H4–H5 loop. Although there is a
density feature consistent with the shape and size of a CBL
attached to Cys112, nevertheless the density is significantly
Figure 4. Snapshots from the 10-ns molecular dynamics simulation of the hGSTA1-1/GSH–CBL complex. (A) t = 0, (B) t = 2.1 ns and (C)
t = 9.0 ns. Atom colors are cyan and orange for the C atoms of GST and GSH–CBL, respectively, blue for N, red for O, yellow for S and green for Cl.
doi:10.1371/journal.pone.0056337.g004
Figure 5. Time course of inactivation of recombinant hGSTA1-1
by CBL at pH 7. Enzyme incubated in the absence (N) or in the
presence of 2 mM CBL (#). Enzyme incubated with 2 mM CBL in the
presence of S-nitrobenzyl-GSH (1 mM) (%). Maleimide-modified en-
zyme incubated with 2 mM CBL (&). At the times indicated, aliquots
were withdrawn and assayed for enzymatic activity.
doi:10.1371/journal.pone.0056337.g005
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fragmented and model building is not possible for that region of
the structure.
Discussion
Resistance to anticancer chemotherapeutic drugs remains a
major obstacle in cancer chemotherapy [7,8]. GSH is a critical
determinant in tumor cell resistance to alkylating cytostatic agents.
This has been attributed to the ability of GSH to compete with
DNA for drug binding. The actual structures of these drug-GSH
conjugates have been characterized for a number of these agents,
such as melphalan, chlorambucil, and cisplatin [7,38,48,49]. In
the present work we showed that hGSTA1-1 interacts with CBL in
two different ways, depending on the presence or absence of GSH.
In the presence of GSH, CBL acts as an efficient substrate for
hGSTA1-1. Kinetic analysis for GSTs has been reported for a vast
number of compounds and the kinetic mechanism has been
clarified [21,50–52]. In general, kinetic mechanism of the GST-
catalyzed conjugation reaction is very complex and class
dependent. For example, several catalytic mechanisms, including
random, ping-pong, and sequential, have been proposed [21,50–
52], but random binding order of substrates seems to prevail. In
Figure 6. Dependence of the pseudo-first-order rate constant for the fast (&) and slow (N) phase of inactivation on CBL
concentration. hGSTA1-1 was incubated with various concentrations of CBL (0.5–3 mM) and the rate constants were calculated as described in the
text.
doi:10.1371/journal.pone.0056337.g006
Figure 7. Structural representation illustrating the lock-and-key motif in hGSTA1-1 and a possible mode of communication
between the two subunits. The key residues Met51, Phe52, Cys112 and the GSH–CBL adducts are shown in licorice representation.
doi:10.1371/journal.pone.0056337.g007
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the case of hGSTA1-1 it has been demonstrated that the enzyme
displays an all-of-the-sites reactivity for nucleophilic aromatic
substitution reactions, whereas a half-of-the-sites reactivity has
been suggested for addition reactions [53].
The structure of another GST family member (human GSTP1-
1) has been solved in complex with the GSH-CBL adduct (PDB
entry 3CSH) [54]. In that structure, the CBL molecule is also
partially exposed to the solvent, nevertheless it makes a few specific
interactions with protein residues. Similarly to our structure, the
Phe8 residue (corresponding to Phe10 of hGSTA1-1) is shifted
towards the CBL molecule, thus enhancing p-p type interactions.
However, when the two structures are superimposed it is evident
that the CBL ring plane is located in different positions (Figure 8).
This observation may be the consequence of significantly different
H-site structures between the two isoenzymes due to the absence
of conserved residues, and of a significant rotation of the small
subdomain containing the H2 and H9 helices with respect to the
large protein subdomain. In addition, it is well established that the
function of the H-site is to accommodate xenobiotics at close
proximity with the GSH cosubstrate, thus facilitating their
enzyme-catalyzed conjugation. Due to its promiscuity for many
different types of hydrophobic molecules, relatively shallow pocket
shape and rare occurrence of polar residues, the H-site naturally
does not feature a conserved binding mode for similar ligands. It is,
therefore, expected that different GST classes are not likely to
have preserved binding modes. In the GSH-CBL adduct, its high
mobility and the absence of specific interactions between CBL and
the enzyme suggest that the covalent bond formed between GSH
and CBL is likely to be the main restraining factor for CBL in this
position.
In the absence of GSH, CBL behaves as an irreversible inhibitor
of hGSTA1-1. The enzyme inactivation by CBL exhibited
biphasic kinetics although only approximately 1 mol of CBL per
mol of enzyme was incorporated and only one catalytic site was
modified in the enzyme dimer. In addition, compound S-
nitrobenzyl-GSH that provided protection against inactivation,
had the same effect for both phases of the inactivation. These
observations imply that CBL binds at the same type of site during
the reaction course. The biphasic kinetics observed may be
explained by assuming that the two subunits, or at least the
conformation or the dynamics of the Cys121 side chains of the
subunits, are not equivalent towards the CBL reaction thus
exhibiting different reactivity. In this context, Figure 3 depicts a
plot of the RMSF (root mean square fluctuations) along the
polypeptide chain, thus providing an indication of the relative
flexibility of the different portions of the protein. Cys112 is located
in one of the two regions with the highest mobility. The crystal
structure shows that, while that region has well defined structure in
monomer A, it is disordered in monomer B. While it is possible
that differences in crystal contacts could account for such
differences, one cannot rule out the possibility of an influence of
the interaction between CBL and Cys112 on the monomer B. It is,
therefore, reasonable to assume that conformational changes and
changes in dynamics may account for the observed biphasic
kinetics.
The active hGSTA1-1 enzyme is a homodimer. It has been a
matter of debate whether the two monomers act independently or
cooperatively in catalysis [36,54–56]. An average incorporation of
1 mol of CBL per mol of enzyme dimer indicates that reaction of
CBL with one Cys112 prevents the reaction of the Cys112 of the
Figure 8. Superimposed crystallographic structures of hGSTA1-1 (PDB ID: 4HJ2, polypeptide ribbon and carbon atoms in cyan) and
hGSTP1-1 (PDB ID: 3CSH, polypeptide ribbon and carbon atoms in orange) complexes with the GSH–CBL adduct. The interacting
Phe10/Phe8 residue of hGST A1-1/P1-1 is shown for comparison.
doi:10.1371/journal.pone.0056337.g008
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second subunit, a finding indicative of intersubunit communica-
tion. Several structures of homodimeric GSTs with bound
products or product analogues have been published, showing no
detectable asymmetry between the subunits. However, Grahn et
al. [57] have shown that the C-terminal region can adopt an
ordered helix-like structure even in the apo state, showing a strong
tendency to unwind. In one subunit (subunit B) the C-terminal
region in the apo structure is more ordered than the other,
suggesting that the subunits are not equivalent. Subunit B seems
better suited to bind a ligand, possibly activating the other subunit
by conformational changes.
Steady-state kinetics with GSTs from several classes using
CDNB and 1,2-dichloro-4-nitrobenzene as electrophilic substrates
are consistent with the pattern of two noncooperative binding sites.
However, active site titration of hGSTA1-1 with 1,3,5-trinitro-
benzene (TNB) showed that maximal saturation of hGSTA1-1
occurs at 1 mol of TNB per mol of enzyme dimer [58]. Half-of-
the-sites reactivity was also postulated for human GSTT2–2, based
on stopped-flow analysis of pre-steady-state kinetic data [59].
Furthermore, the published crystal structure of the mouse
mGSTA4-4 [60] and soy GmGSTU4-4 [18] showed that, although
GSH was bound at the active sites of both monomers, only one
subunit appeared to be catalytically active at a time.
Analysis of the crystal structure of hGSTA1-1 provides a
structural basis for the intrasubunit communication operating
upon reaction of Cys112 with CBL (Figure 7). Although the H-
sites of neighbouring subunits are distant, a plausible mode of
communication between them is conceivable. Structural exami-
nation (Figure 7) reveals that the key residue bridging the dimer
interface, Phe52, may play an important role in intrasubunit
communication. This residue, together with Met51, forms the
lock-and-key motif which is responsible for a highly conserved
hydrophobic interaction in the subunit interface. These residues
make contact with a hydrophobic patch on the alternate subunit,
comprising in part of Met94, Phe136, and Val139. Since the
interface contacts on the alternate subunit are largely found in a
single kinked a-helix H3, the signal may be transmitted via the
helix H3 to Cys112, which is located at the end of this helix.
Conformational changes of this residue may abolish reaction of
CBL with Cys112 at the second subunit. Thus, the observed
intrasubunit communication is probably directed via Phe52 of the
monomer-monomer contact region, to a-helix H3 of the adjacent
subunit which contains Cys112. Misquitta and Colman [56], using
wild-type-mutant heterodimers of hGSTA1-1 have shown that
mutation of an amino acid residue in one active site affects the
activity in the other active site. Modelling studies, moreover,
showed that key amino acid residues and water molecules connect
the two active sites and this connectivity is responsible for the
cross-talk between the active sites [56]. These results are in concert
with a ‘co-operative self-preservation’ mechanism, as proposed by
Ricci et al. [61] for the human P1-1 isoenzyme. According to this
mechanism, a co-operativity is utilized by the enzyme to provide
self-preservation against inhibitors or physical factors, which
threaten its catalytic ability. This mechanism is based on a
structural intersubunit communication, by which one subunit, as a
consequence of a modification, triggers a defence arrangement in
the other subunit to prevent modification [61].
In conclusion, in the present work we investigated the
interaction of the chemotherapeutic drug CBL with hGSTA1-1.
Analysis of the crystal structure of hGSTA1-1/CBL-GSH
complex showed that the CBL moiety, bound in the H-site, is
partially ordered, exposed to the solvent making only a few specific
interactions with the enzyme. Molecular dynamics simulations
based on the crystal structure indicated high mobility for the CBL
moiety and stabilization of the C-terminal helix due to the
presence of the adduct. In the absence of GSH, CBL is shown to
be an alkylating irreversible inhibitor for hGSTA1-1, modifying
specifically Cys112 only in one subunit. These results suggest the
existence of a structural communication between subunits,
confirming that the two enzyme active sites are presumably
coordinated.
Supporting Information
Figure S1 Fo-Fc electron density map contoured at 2.7s
showing electron density corresponding to bound GSH–
CBL, superimposed on refined crystal structure.
(TIF)
Figure S2 Root mean square fluctuation (RMSF) of GST
A1-1 Ca atoms calculated for the GSH (black) and the
GSH–CBL (red) complexes from 10-ns molecular dy-
namics. The graph shows the mean RMSF value from the two
monomers.
(TIF)
Figure S3 Root mean square deviations (RMSD) of GSH
(black curve) and CBL moiety (red curve) atomic
positions as a function of MD simulation time. Top
graph is for monomer A and bottom graph is for monomer B.
(TIF)
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